Signaturefd LLC Has $970,000 Holdings in Agilent Technologies, Inc. (NYSE:A)

Signaturefd LLC boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,223 shares of the medical research company’s stock after buying an additional 226 shares during the quarter. Signaturefd LLC’s holdings in Agilent Technologies were worth $970,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of A. CKW Financial Group increased its position in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Hanson & Doremus Investment Management grew its position in shares of Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 105 shares during the last quarter. OFI Invest Asset Management acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $37,000. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of Agilent Technologies in the third quarter valued at approximately $38,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on A shares. JPMorgan Chase & Co. decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. Bank of America decreased their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Robert W. Baird decreased their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday, February 27th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, Sanford C. Bernstein reduced their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $146.15.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Stock Up 0.5 %

NYSE A opened at $123.10 on Wednesday. The business has a fifty day moving average price of $137.70 and a two-hundred day moving average price of $137.68. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. Agilent Technologies, Inc. has a fifty-two week low of $117.17 and a fifty-two week high of $155.35. The stock has a market capitalization of $35.09 billion, a PE ratio of 28.30, a PEG ratio of 3.40 and a beta of 1.11.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Equities analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.